{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:58:35Z","timestamp":1758808715994},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[1982,8,1]],"date-time":"1982-08-01T00:00:00Z","timestamp":397008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1982,8]]},"DOI":"10.1007\/bf01728351","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T00:34:08Z","timestamp":1118622848000},"page":"847-852","source":"Crossref","is-referenced-by-count":3,"title":["Rapid increase of mineralocorticoids after furosemide in low-renin essential hypertension: Evidence for 18-hydroxycorticosterone to be a better marker than aldosterone"],"prefix":"10.1007","volume":"60","author":[{"given":"H.","family":"Witzgall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Thayil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01728351_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/jcem-49-1-87","volume":"49","author":"EG Biglieri","year":"1979","unstructured":"Biglieri EG, Schambelan M (1979) The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism. J Clin Endocrinol Metab 49:87\u201391","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1172\/JCI109356","volume":"63","author":"RM Carey","year":"1979","unstructured":"Carey RM, Thorner MO, Ortt EM (1979) Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. J Clin Invest 63:727\u2013735","journal-title":"J Clin Invest"},{"key":"BF01728351_CR3","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1172\/JCI109582","volume":"64","author":"RG Dluhy","year":"1979","unstructured":"Dluhy RG, Bavli SZ, Leung FK, Solomon HS, Moore TJ, Hollenberg NK, Williams GH (1979) Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. J Clin Invest 64:1270\u20131276","journal-title":"J Clin Invest"},{"key":"BF01728351_CR4","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1172\/JCI109997","volume":"66","author":"RV Farese","year":"1980","unstructured":"Farese RV, Sabir MA, Larson RE (1980) Potassium and angiotensin II increase the concentrations of phosphatidic acid, phosphatidylinositol, and polyphosphoinositides in rat adrenal capsules in vitro. J Clin Invest 66:1428\u20131431","journal-title":"J Clin Invest"},{"key":"BF01728351_CR5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0022-4731(78)90161-9","volume":"9","author":"R Fraser","year":"1978","unstructured":"Fraser R, Lantos CP (1978) 18-Hydroxycorticosterone: a review. J Steroid Biochem 9:273\u2013286","journal-title":"J Steroid Biochem"},{"key":"BF01728351_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0161-4630(81)90084-7","volume":"6","author":"JG Gerber","year":"1981","unstructured":"Gerber JG, Nies AS (1981) Interaction between furosemide-induced renal vasodilation and the prostaglandin system. Prostaglandins and Medicine 6:135\u2013145","journal-title":"Prostaglandins and Medicine"},{"key":"BF01728351_CR7","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/jcem-29-10-1349","volume":"29","author":"E Haber","year":"1969","unstructured":"Haber E, Koerrer T, Page LB, Kliman B, Purnode A (1969) Application of radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29:1349\u20131353","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR8","first-page":"201","volume":"61","author":"G Huston","year":"1981","unstructured":"Huston G, Martin VJ, Al-Dujaili EAS, Edwards CRW (1981) Evaluation of the mineralocorticoid activity of 18-hydroxy-corticosterone. Clin Sci Mol Med 61:201\u2013206","journal-title":"Clin Sci Mol Med"},{"key":"BF01728351_CR9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/01.RES.38.6.502","volume":"38","author":"ES Kisch","year":"1976","unstructured":"Kisch ES, Dluhy RG, Williams GH (1976) Enhanced aldosterone response to angiotensin II in human hypertension. Circ Res 38:502\u2013505","journal-title":"Circ Res"},{"key":"BF01728351_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1210\/jcem-51-2-337","volume":"51","author":"O Kuchel","year":"1980","unstructured":"Kuchel O, Buu NT, Vecsei P, Bourque M, Hamet P, Genest J (1980) Are plasma aldosterone surges in primary aldosteronism due to a loss of an inhibitory dopaminergic control? J Clin Endocrinol Metab 51:337\u2013344","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/292367a0","volume":"292","author":"EG Lapetina","year":"1981","unstructured":"Lapetina EG, Billah MM, Cuatrecasas P (1981) The phosphatidylinositol cycle and the regulation of arachidonic acid production. Nature 292:376\u2013369","journal-title":"Nature"},{"key":"BF01728351_CR12","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1210\/jcem-43-5-1170","volume":"43","author":"DT Matulich","year":"1976","unstructured":"Matulich DT, Spindler BJ, Schambelan M, Baxter JD (1976) Mineralocorticoid receptors in human kidney. J Clin Endocrinol Metab 43:1170\u20131174","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR13","first-page":"25P","volume":"81","author":"R Neher","year":"1979","unstructured":"Neher R (1979) Aldosterone: chemical aspects and related enzymology. J Endocrinol 81:25P-35P","journal-title":"J Endocrinol"},{"key":"BF01728351_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(81)90424-4","volume":"VII","author":"PL Padfield","year":"1981","unstructured":"Padfield PL, Davies D, Lever AF, Brown JJ, Fraser R, Morton JJ, Robertson JIS (1981) The myth of idiopathic hyperaldosteronism. Lancet VII:83\u201384","journal-title":"Lancet"},{"key":"BF01728351_CR15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1055\/s-0028-1107825","volume":"14","author":"R R\u00f6ssler","year":"1974","unstructured":"R\u00f6ssler R, Gaiser H (1974) Plasmaaldosteron und Reninaktivit\u00e4t bei Gesunden unter Natriumzufuhr und Natriumentzug. Dtsch Med Wochenschr 14:685\u2013689","journal-title":"Dtsch Med Wochenschr"},{"key":"BF01728351_CR16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.1980.tb02738.x","volume":"12","author":"PF Semple","year":"1980","unstructured":"Semple PF, Mason PA, Fraser R (1980) Increased 18-hydroxycorticosterone responses to furosemide in essential hypertension. Clin Endocrinol 12:473\u2013481","journal-title":"Clin Endocrinol"},{"key":"BF01728351_CR17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/jcem-52-3-440","volume":"52","author":"ML Tuck","year":"1981","unstructured":"Tuck ML, Sowers JR, Asp ND, Viosca SP, Berg G, Mayes DM (1981) Mineralocorticoid responses to low dose adrenocorticotropin infusion. J Clin Endocrinol Metab 52:440\u2013446","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR18","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/S0021-9258(19)70823-0","volume":"237","author":"W Ulick","year":"1962","unstructured":"Ulick W, Vetter KK (1962) Identification of two C18 oxygenated corticosteroids isolated from human urine. J Biol Chem 237:3364\u20133369","journal-title":"J Biol Chem"},{"key":"BF01728351_CR19","first-page":"67","volume-title":"Aldosterone","author":"S Ulick","year":"1964","unstructured":"Ulick S, Nicolis GL, Vetter KK (1964) 18-OH-corticosterone to aldosterone. In: Boulien EG, Rober P (eds) Aldosterone, Blackwell, Oxford, pp 67\u201378"},{"key":"BF01728351_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0014-2999(77)90326-0","volume":"41","author":"PC Weber","year":"1977","unstructured":"Weber PC, Scherer B, Larsson C (1977) Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release. Eur J Pharmacol 41:329\u2013332","journal-title":"Eur J Pharmacol"},{"key":"BF01728351_CR21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI109318","volume":"63","author":"GH Williams","year":"1979","unstructured":"Williams GH, Hollenberg NK, Moore TJ, Swartz SL, Dluhy RG (1979) The adrenal receptor for angiotensin II is altered in essential hypertension. J Clin Invest 63:419\u2013427","journal-title":"J Clin Invest"},{"key":"BF01728351_CR22","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI109065","volume":"61","author":"M Wisgerhof","year":"1978","unstructured":"Wisgerhof M, Brown RD (1978) Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension. J Clin Invest 61:1456\u20131462","journal-title":"J Clin Invest"},{"key":"BF01728351_CR23","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1210\/jcem-47-5-938","volume":"47","author":"M Wisgerhof","year":"1978","unstructured":"Wisgerhof M, Carpenter PC, Brown RD (1978) Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism. J Clin Endocrinol Metab 47:938\u2013943","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1210\/jcem-49-1-107","volume":"49","author":"M Wisgerhof","year":"1979","unstructured":"Wisgerhof M, Brown RD (1979) The metabolic clearance of aldosterone decreases similarly during infusion of angiotensin II in patients with essential hypertension and in normal subjects. J Clin Endocrinol Metab 49:107\u2013109","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/jcem-52-2-195","volume":"52","author":"M Wisgerhof","year":"1981","unstructured":"Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AJ (1981) The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab 52:195\u2013198","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01728351_CR26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0021-9673(00)81198-X","volume":"198","author":"H Witzgall","year":"1980","unstructured":"Witzgall H, Hassan-Ali S (1980) Paper chromatographic systems for the preparation of aldosterone, 18-hydroxycorticosterone, 18-hydroxydeoxycorticosterone, corticosterone and deoxycorticosterone. J Chromatogr 198:70\u201375","journal-title":"J Chromatogr"},{"key":"BF01728351_CR27","first-page":"387","volume":"13","author":"H Witzgall","year":"1981","unstructured":"Witzgall H, Hassan-Ali S (1981) A simultaneous radioimmunoassay for aldosterone and its precursors. Human plasma levels following converting-enzyme inhibition before and after block-ade of prostaglandin biosynthesis. J Clin Chem Clin Biochem 13:387\u2013394","journal-title":"J Clin Chem Clin Biochem"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01728351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01728351\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01728351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T19:40:16Z","timestamp":1626032416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01728351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,8]]},"references-count":27,"journal-issue":{"issue":"16","published-print":{"date-parts":[[1982,8]]}},"alternative-id":["BF01728351"],"URL":"https:\/\/doi.org\/10.1007\/bf01728351","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,8]]}}}